Study shows no benefits of antidepressant for COVID-19 symptoms - UPI.com Researchers studied fluvoxamine because previous evidence suggested that it might be able to reduce inflammation caused by the virus. UPI

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

Florida's COVID-19 death toll: Nearly 91K fatalities reported statewide The number of Florida residents who have died of COVID-19 since early 2020 is nearing 91,000. CBS Miami

...

The new data said 70,533 of the deaths, or nearly 78 percent, involved people age 65 or older. Also, 77,371 of the deaths, or about 85 percent, involved people 60 or older.

...

"Nightmare," Some planning to get new COVID-19 vaccine getting bills for nearly $200 Some people planning to get the new COVID-19 vaccine are getting bills for nearly $200. CBS Boston

...

According to both CVS and the Centers for Medicare and Medicaid Services, the new vaccines have a new billing code for insurances – which has not been updated in all insurance plans, leading to the erroneous charge for people seeking out a vaccine in this first week.

More people becoming susceptible to COVID-19, doctors say new vaccine reduces severity Several doctors believe that the newly updated vaccine is the best course of action, as some people are becoming more susceptible to COVID than others. Kayleigh Thomas WWLP

...

Covid-19 vaccination rates lag behind flu’s, but getting shots together may help | CNN Every year since 2010, the US Centers for Disease Control and Prevention has recommended everyone in the country aged 6 months and older receive an annual flu shot. Meg Tirrell CNN

...

Germany kicks off autumn COVID vaccine campaign targeting high-risk groups Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19 booster shot only for the elderly or for people at high disease risks. Reuters Reuters

...

COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it. Fortune

U.S. COVID infections are hovering near levels of the pandemic’s first peak in 2020, and approaching the Delta peak of late 2021, according to wastewater surveillance and modeling by forecasters. ...

Climate change impeding fight against AIDS, TB and malaria Climate change and conflict are hitting efforts to tackle three of the world's deadliest infectious diseases, the head of the Global Fund to Fight AIDS, Tuberculosis and Malaria has warned. Jennifer Rigby Reuters

...

A new COVID vaccine is here, but those at greatest risk may not get it as outreach drops off The CDC says everyone over 6 months old should get the new COVID vaccine. But with the emergency response mechanisms that supported earlier vaccine campaigns gone, many who need them most won’t get them. PBS NewsHour

...